Immunome Inc.
IMNM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472012
In the last 90 days, Immunome Inc. insiders filed 0 open-market purchases and 7 sales; 202 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Immunome Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 29 | 35 | +6 |
| Shares | 2.38M | 2.39M | +15.3K (+0.6%) |
| Value | $41.1M | $58.3M | +$17.2M (+41.9%) |
New holders (13)
Institutions that held Immunome Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of Montreal | 92,593 | $2.35M | 0.00% |
| Susquehanna International Group, LLP | 58,881 | $1.43M | 0.00% |
| Citadel Advisors LLC | 18,348 | $447.0K | 0.00% |
| HAP Trading, LLC | 17,922 | $436.0K | 0.03% |
| Northern Trust Corp | 16,798 | $409.0K | 0.00% |
| State Street Corp | 12,700 | $309.0K | 0.00% |
| Virtu Financial LLC | 10,904 | $266.0K | 0.02% |
| Price T Rowe Associates Inc | 10,800 | $263.0K | 0.00% |
| Baldwin Investment Management, LLC | 9,196 | $224.0K | 0.04% |
| Marshall Wace, LLP | 8,348 | $203.0K | 0.00% |
| Lindbrook Capital, LLC | 1,000 | $24.0K | 0.01% |
| Cutler Group LP | 719 | $17.0K | 0.00% |
| US Bancorp | 112 | $3.00K | 0.00% |
Sold out (7)
Institutions that held Immunome Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Two Sigma Investments, LP | 29,516 | $511.0K |
| Renaissance Technologies LLC | 20,400 | $353.0K |
| ExodusPoint Capital Management, LP | 12,800 | $221.0K |
| Ergoteles LLC | 10,006 | $173.0K |
| JPMorgan Chase & Co | 768 | $13.0K |
| Tower Research Capital LLC (TRC) | 100 | $2.00K |
| New York State Common Retirement Fund | 17 | $0 |